Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sylvamo (SLVM) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Sylvamo (SLVM) over the last 6 years, with Q3 2025 value amounting to $57.0 million.

  • Sylvamo's Accumulated Expenses fell 2500.0% to $57.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.0 million, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $79.0 million for FY2024, which is 2539.68% up from last year.
  • As of Q3 2025, Sylvamo's Accumulated Expenses stood at $57.0 million, which was down 2500.0% from $53.0 million recorded in Q2 2025.
  • Sylvamo's 5-year Accumulated Expenses high stood at $81.0 million for Q4 2022, and its period low was $46.0 million during Q1 2022.
  • Its 5-year average for Accumulated Expenses is $60.2 million, with a median of $56.0 million in 2022.
  • As far as peak fluctuations go, Sylvamo's Accumulated Expenses tumbled by 2941.18% in 2021, and later surged by 6875.0% in 2022.
  • Sylvamo's Accumulated Expenses (Quarter) stood at $48.0 million in 2021, then surged by 68.75% to $81.0 million in 2022, then decreased by 22.22% to $63.0 million in 2023, then increased by 25.4% to $79.0 million in 2024, then fell by 27.85% to $57.0 million in 2025.
  • Its last three reported values are $57.0 million in Q3 2025, $53.0 million for Q2 2025, and $52.0 million during Q1 2025.